These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2186581)

  • 21. [Study on recombinant BCG].
    Matsuo K; Yamaguchi R; Yamazaki A; Terasaka K; Nagai S; Tasaka H; Abe C; Totsuka M; Yukitake H; Kobayashi K
    Kekkaku; 1991 Sep; 66(9):615-9. PubMed ID: 1942733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
    Aldovini A; Young RA
    Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The secretome of a recombinant BCG substrain reveals differences in hypothetical proteins.
    Rodríguez-Alvarez M; Palomec-Nava ID; Mendoza-Hernández G; López-Vidal Y
    Vaccine; 2010 May; 28(23):3997-4001. PubMed ID: 20153797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on gene knock-out in Mycobacterium BCG].
    Chen XY; Li CY; Ma Y; Liu C; Wang JH; Zhang XF; Chang ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):183-7. PubMed ID: 15130330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A stable Escherichia coli-mycobacteria shuttle vector 'pSO246' in Mycobacterium bovis BCG.
    Matsumoto S; Tamaki M; Yukitake H; Matsuo T; Naito M; Teraoka H; Yamada T
    FEMS Microbiol Lett; 1996 Jan; 135(2-3):237-43. PubMed ID: 8595863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen.
    Bruffaerts N; Pedersen LE; Vandermeulen G; Préat V; Stockhofe-Zurwieden N; Huygen K; Romano M
    PLoS One; 2015; 10(7):e0132288. PubMed ID: 26172261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant BCG as an antigen delivery system.
    Flynn JL
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():31-6. PubMed ID: 7950859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives and limitations of the mycobacterial expression system.
    Villar C; Benítez J
    Arch Med Res; 1994; 25(4):451-3. PubMed ID: 7858406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes.
    Oliveira TL; Rizzi C; Dellagostin OA
    Appl Microbiol Biotechnol; 2017 Sep; 101(18):6865-6877. PubMed ID: 28779291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of a working seed lot of BCG and quality control by PCR genotyping.
    Trovero A; Argüelles C; Cataldi A
    Rev Argent Microbiol; 2010; 42(1):4-10. PubMed ID: 20461286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative genomics of BCG vaccines by whole-genome DNA microarray.
    Behr MA; Wilson MA; Gill WP; Salamon H; Schoolnik GK; Rane S; Small PM
    Science; 1999 May; 284(5419):1520-3. PubMed ID: 10348738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccine.
    Lugosi L
    Dev Biol Stand; 1992; 77():211-5. PubMed ID: 1426664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New use of BCG for recombinant vaccines.
    Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF
    Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].
    Prygiel M; Janaszek-Seydlitz W; Bucholc B
    Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The uraA locus and homologous recombination in Mycobacterium bovis BCG.
    Aldovini A; Husson RN; Young RA
    J Bacteriol; 1993 Nov; 175(22):7282-9. PubMed ID: 8226675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the bacille Calmette-Guérin vaccine strain currently being used in Iran.
    Fallah F; Karimi A; Abdolghafoorian H; Mohammadzadeh A; Zahraei SM; Goudarzi H; Fallah M
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):223-7. PubMed ID: 26792475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.
    Mazzantini RP; Miyaji EN; Dias WO; Sakauchi D; Nascimento AL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
    Vaccine; 2004 Jan; 22(5-6):740-6. PubMed ID: 14741167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.